iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Shree Ganesh Biotech (India) jumps after board OKs 1:1 bonus issue

8 Mar 2022 , 01:08 PM

Pre-bonus issue, the paid up equity share capital as on the date stood at Rs 19,93,12,000 consisting of 19,93,12,000 equity shares of Rs 1 each. Post bonus issue, the paid up equity share capital shall be Rs 39,86,24,000 consisting of 39,86,24,000 equity shares of Rs 1 each.

Shree Ganesh Biotech (India)s net profit surged 156.8% to Rs 0.95 crore on a 142.7% increase in net sales to Rs 19.03 crore in Q3 FY22 over Q3 FY21.

Shree Ganesh Biotech (India) is engaged in the trading of seeds and bhushi. It is mainly into the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.